Scientists hunt for early warning signs of inherited nerve disease
NCT ID NCT07476365
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find early biological markers (biomarkers) for Charcot-Marie-Tooth disease type 1A (CMT1A), a common inherited nerve disorder. Researchers will analyze blood and nerve samples from 70 people aged 10-30 with CMT1A, along with animal models, to identify signs that predict how the disease will progress. The goal is to enable future clinical trials for treatments that could be given in childhood, before permanent nerve damage occurs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CMT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Medical Centre
RECRUITINGGöttingen, 37075, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden nerve damage: new study probes autonomic symptoms in CMT patients
- CMT tremor mystery: new study aims to uncover hidden symptoms
- New study aims to unravel nerve mysteries in rare diseases
- Scientists launch 5-Year quest to unlock CMT1A's secrets
- Could a single DNA test solve the mystery of rare brain diseases in kids?
- Gene therapy injection tested for rare nerve disease